|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2008-12-18
|
|
pubmed:abstractText |
Platelet-induced thrombosis is a major risk factor for recurrent ischemic events, although platelet function in patients with cardiovascular disease taking aspirin and clopidogrel is very poorly characterized. The aim of this study was to assess platelet reactivity in patients with cardiovascular disease taking aspirin and clopidogrel.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1538-7836
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2027-34
|
|
pubmed:dateRevised |
2009-4-16
|
|
pubmed:meshHeading |
pubmed-meshheading:18823340-Adenosine Diphosphate,
pubmed-meshheading:18823340-Aged,
pubmed-meshheading:18823340-Aspirin,
pubmed-meshheading:18823340-Case-Control Studies,
pubmed-meshheading:18823340-Coronary Artery Disease,
pubmed-meshheading:18823340-Drug Therapy, Combination,
pubmed-meshheading:18823340-Epinephrine,
pubmed-meshheading:18823340-Female,
pubmed-meshheading:18823340-Humans,
pubmed-meshheading:18823340-Male,
pubmed-meshheading:18823340-Middle Aged,
pubmed-meshheading:18823340-Platelet Activation,
pubmed-meshheading:18823340-Platelet Aggregation Inhibitors,
pubmed-meshheading:18823340-Platelet Function Tests,
pubmed-meshheading:18823340-Ticlopidine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease.
|
|
pubmed:affiliation |
Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland. apeace@rcsi.ie
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
